Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data-Reference-Cited by-全球学者库

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Published:2021-05 Issue:10287 Volume:397 Page:1819-1829
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Haas Eric J,Angulo Frederick J,McLaughlin John M,Anis Emilia,Singer Shepherd R,Khan Farid,Brooks Nati,Smaja Meir,Mircus Gabriel,Pan Kaijie,Southern Jo,Swerdlow David L,Jodar Luis,Levy Yeheskel,Alroy-Preis Sharon

Publisher

Elsevier BV

Subject

General Medicine

Reference18 articles.

1. SARS-CoV-2 vaccines and the growing threat of viral variants;Moore;JAMA,2021

2. UK COVID-19 variant detected in Israel, health ministry says;Ayyub,2020

3. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine;Polack;N Engl J Med,2020

4. Vaccine effectiveness after 1st and 2nd dose of the BNT162b2 mRNA COVID-19 vaccine in long-term care facility residents and healthcare workers—a Danish cohort study;Moustsen-Helms;medRxiv,2021

5. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients;Amit;Lancet,2021

Cited by 1336 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and limitations of repurposed drugs and vaccines for COVID-19;Journal of Medicine, Surgery, and Public Health;2024-04

2. Intranasal Drug Delivery of Antiviral Agents - A Revisit and Way Forward;Current Drug Therapy;2024-03

3. SARS-CoV-2 seroprevalence and associated factors of infection before and after the Delta wave in French Polynesia: a cross-sectional study;BMC Public Health;2024-02-05

4. The age-specific impact of COVID-19 vaccination on medical expenditures and hospitalization duration after breakthrough infection: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study;Vaccine;2024-02

5. Vaccines reduced hospital length of stay and fraction of inspired oxygen of COVID-19 patients: A retrospective cohort study;Preventive Medicine Reports;2024-02